The Daily Buyout

The archive

Every deal we've covered

1,792 deals tracked since Aug 26, 2026, worth $628B in announced deal value. Every link is free to read.

1,792 deals · $257M announced on this pagePage 67 of 90
50+ port terminalsPrivate equity buyoutTransportation & LogisticsSep 28, 2026

A.P. Moller Capital takes majority stake in port operator Euroports

A.P. Moller Capital has agreed, through a separately managed fund vehicle, to acquire a majority stake in Euroports Group, which runs more than 50 deep-sea and inland terminals across 10 European countries and China and handles over 70 million tonnes of cargo a year. Existing shareholders SFPIM and PMV will stay on, and management, governance and strategy remain unchanged. Terms were not disclosed.

19.1% stakeMinority stakeTechnologySep 28, 2026

Siris to buy 19.1% of Agfa-Gevaert from Active Ownership

Private equity firm Siris Capital has agreed to acquire a 19.1% stake in Euronext Brussels-listed Agfa-Gevaert from Active Ownership, on undisclosed terms. The move follows Siris's earlier agreement to combine Agfa's Digital Printing Solutions business with portfolio company EFI, a venture Siris will own 60% of and Agfa 40%. The stake purchase is conditioned on that combination closing.

27 aircraftStrategic acquisitionAerospace & DefenseCompletedSep 28, 2026

FTAI Aviation buys 27 Boeing 737-700s from WestJet

FTAI Aviation has acquired 27 Boeing 737-700 aircraft from WestJet in one of its largest aircraft transactions to date. FTAI's 2026 SPV, the second vehicle of its Strategic Capital business, took 17 jets on lease to WestJet in a sale-leaseback, while FTAI itself bought 10 off-lease aircraft to feed CFM56-7B engines and modules into its Aerospace Products exchange pool.

~$929MreportedStrategic acquisitionHealthcare & Life SciencesCompletedSep 28, 2026

Zymeworks closes Theravance Biopharma buy, adds YUPELRI cash flow

Zymeworks has completed its acquisition of Theravance Biopharma and issued final transaction details with updated 2026 guidance. The deal brings YUPELRI (revefenacin) into the portfolio, entitling Zymeworks to 35% of net U.S. profits plus ex-U.S. royalties via Theravance's Viatris collaboration. YUPELRI sales of $133.1 million in the first half of 2026 generated $38.4 million of collaboration revenue.

$255MStrategic acquisitionEnergy & UtilitiesSep 28, 2026

Jefferson to buy USD Group crude logistics assets for $255M

FTAI Energy Partners, the Jefferson subsidiary of FTAI Infrastructure, agreed to acquire the Port Arthur Terminal in Texas and a 50% interest in the Hardisty, Alberta Diluent Recovery Unit from a USD Group subsidiary for roughly $255 million in cash. The purchase will be financed by assuming existing debt plus a new acquisition facility, and management expects about $50 million of annual EBITDA. Closing awaits regulatory approvals in the fourth quarter of 2026.

~$670MreportedStrategic acquisitionFinancial ServicesSep 28, 2026

S-Bank secures 96.6% of Oma Savings Bank in cash tender offer

S-Bank Plc said 32,088,337 shares were validly tendered in its voluntary recommended public cash tender offer for Oma Savings Bank Plc, representing about 96.58% of all issued and outstanding shares and votes, excluding treasury shares. The offer, announced July 9 and open from July 17, expired September 25. S-Bank will confirm the final result on or about September 30.